Glycolytic rate-limiting enzymes determine the key nodes from glucose uptake and flux commitment to pyruvate formation. Hexokinase, phosphofructokinase, and pyruvate kinase respectively control early substrate trapping, irreversible mid-pathway flux commitment, and terminal ATP generation in glycolysis. Their regulatory modes directly affect cellular energy metabolism, lactate production, anabolic energy supply, and metabolic reprogramming in tumors, immunity, and hypoxic responses.

Keywords: glycolytic rate-limiting enzymes; hexokinase; phosphofructokinase; pyruvate kinase; glycolytic flux; metabolic reprogramming; PKM2; tumor metabolism

1 Functional Positioning of Glycolytic Rate-Limiting Enzymes

1.1 Three Control Nodes of Glycolytic Flux

Glycolysis is not a simple linear process of stepwise glucose degradation, but a flux network jointly controlled by multiple irreversible reactions and metabolic feedback. Hexokinase (HK), phosphofructokinase-1 (PFK-1), and pyruvate kinase (PK) catalyze three highly irreversible steps in glycolysis and constitute the major rate-limiting nodes of glycolytic regulation.

(1) Hexokinase

HK catalyzes the conversion of glucose into glucose-6-phosphate and serves as the entry reaction of glycolysis. This step traps glucose inside the cell and allows it to enter glycolysis, glycogen synthesis, the pentose phosphate pathway, or the hexosamine biosynthesis pathway. Therefore, HK not only determines the starting point of glucose utilization, but also affects multiple glucose branch pathways.

(2) Phosphofructokinase

PFK-1 catalyzes the conversion of fructose-6-phosphate into fructose-1,6-bisphosphate and is the most typical committed step of glycolysis. This reaction occurs after the multidirectional branching of glucose-6-phosphate. Once carbon flux passes through PFK-1, it is more clearly directed into downstream glycolysis. Therefore, PFK-1 is often regarded as the core rate-limiting enzyme controlling glycolytic flux.

(3) Pyruvate kinase

PK catalyzes the conversion of phosphoenolpyruvate into pyruvate, accompanied by ATP generation, and serves as the terminal energy-output node of glycolysis. PK activity determines whether upstream glycolytic intermediates rapidly flow toward pyruvate or are retained for branches related to nucleotide, amino acid, and lipid synthesis.

1.2 Regulatory Differences Among the Three Types of Rate-Limiting Enzymes

Although all three types of rate-limiting enzymes participate in irreversible reactions in glycolysis, they control different targets. HK mainly determines whether glucose can be captured and phosphorylated by cells; PFK-1 determines whether carbon flux enters the main glycolytic pathway; PK determines terminal carbon flux and ATP generation efficiency. In experiments, glucose consumption or lactate production alone cannot distinguish whether flux changes occur at the entry point, mid-pathway node, or terminal step. Therefore, enzyme expression, enzyme activity, metabolic intermediates, and isotope tracing should be combined for comprehensive interpretation.

2 Hexokinase Regulation: Glucose Trapping and Metabolic Entry Control

2.1 Catalytic Reaction and Functional Characteristics

Hexokinase catalyzes the reaction between glucose and ATP to generate glucose-6-phosphate and ADP. This reaction adds a phosphate group to glucose, limiting its free transmembrane diffusion and completing intracellular glucose trapping. Glucose-6-phosphate can then enter glycolysis, the pentose phosphate pathway, glycogen synthesis, or other glucose metabolic branches. Therefore, increased HK activity usually indicates enhanced cellular demand for glucose utilization, but it does not necessarily mean that all carbon flux enters lactate production.

2.2 Major Isoenzymes and Tissue Differences

(1) HK1

HK1 is stably expressed in many tissues and maintains basal glucose phosphorylation and energy metabolism. Its function is more oriented toward basal metabolic demand, and it can also contribute to stable glycolytic entry in proliferating cells and tumor cells.

(2) HK2

HK2 is highly expressed in embryonic tissues, muscle, and many tumors, and is often associated with high glycolytic activity and the Warburg effect. HK2 can localize to the outer mitochondrial membrane and interact with VDAC, linking glucose phosphorylation with mitochondrial energy status, anti-apoptotic signaling, and tumor cell survival.

(3) HK4/glucokinase

HK4 is mainly distributed in the liver and pancreatic β cells and functions as a sensor of changes in glucose concentration. Its affinity and regulatory mode differ from those of HK1/HK2, making it more suitable for blood glucose sensing and hepatic glucose metabolism regulation.

2.3 Regulatory Mechanisms and Experimental Interpretation

HK is jointly regulated by substrate availability, product feedback, expression level, mitochondrial localization, and cellular energy status. Glucose-6-phosphate can feedback-inhibit some HK isoenzymes. Hypoxia, HIF-1α, PI3K-AKT, MYC, and other signals can promote HK2 expression, enabling cells to enhance glucose uptake and phosphorylation capacity.

(1) Increased HK without synchronous lactate elevation

If HK expression or activity increases while lactate production does not increase significantly, this may indicate that more glucose-6-phosphate enters the pentose phosphate pathway, glycogen synthesis, or other branches. In this case, G6PD, NADPH, nucleotide synthesis indicators, or glycogen-related markers should be detected.

(2) Increased HK2 accompanied by enhanced lactate production

If HK2, glucose uptake, and lactate release increase simultaneously, this usually indicates enhanced glycolytic entry with transmission of flux downstream. This pattern is common in tumor cells, activated immune cells, and hypoxic models.

(3) Enhanced mitochondrial localization of HK2

When HK2 binding to mitochondria increases, this may suggest not only increased glycolytic flux, but also enhanced anti-apoptotic capacity and metabolic adaptability. Such studies can combine the detection of VDAC, mitochondrial membrane potential, apoptosis, and ATP levels.

3 Phosphofructokinase Regulation: The Glycolytic Flux Commitment Step

3.1 Core Rate-Limiting Role of PFK-1

PFK-1 catalyzes the conversion of fructose-6-phosphate into fructose-1,6-bisphosphate and is the most critical flux commitment step in glycolysis. Compared with HK, PFK-1 is located after the branching of glucose-6-phosphate and more directly determines whether carbon flux continues into the main glycolytic pathway. Compared with PK, PFK-1 controls mid-pathway flux entry rather than terminal product formation.

PFK-1 is highly sensitive to energy status. ATP and citrate generally inhibit PFK-1, indicating sufficient energy or accumulation of tricarboxylic acid cycle intermediates. AMP, ADP, and fructose-2,6-bisphosphate can activate PFK-1, indicating energy deficiency or the need for enhanced glycolytic flux.

3.2 PFK-1 and the PFKFB System

PFK-1 itself is subject to allosteric regulation, while the PFKFB family indirectly controls PFK-1 activity by regulating fructose-2,6-bisphosphate levels. Fructose-2,6-bisphosphate is a potent activator of PFK-1 and can reduce the inhibitory effect of ATP on PFK-1, allowing glycolysis to maintain high flux under energy stress, hypoxia, or proliferative conditions.

(1) PFKFB3

PFKFB3 has strong kinase activity and is often upregulated in tumor cells, inflammatory cells, and activated immune cells. Increased PFKFB3 usually indicates increased fructose-2,6-bisphosphate production and enhanced flux commitment capacity of PFK-1.

(2) PFKFB4

PFKFB4 participates in the balance between glycolysis and antioxidant metabolism in some tumors. Its function is not limited to promoting glycolysis; it may also regulate cell survival by affecting reducing power and metabolic branching.

(3) PFK-1 and energy stress

When cellular ATP decreases and AMP increases, PFK-1 is more readily activated, promoting rapid glucose flow toward downstream energy-producing steps. If PFK-1 activity increases but downstream pyruvate or lactate accumulation is not obvious, PK activity, mitochondrial oxidation, metabolic branches, and intermediate accumulation should be considered.

3.3 Key Points for Experimental Interpretation

PFK-1 is an important node for determining whether the main glycolytic flux is truly driven forward. Detection of HK or glucose uptake alone may only reflect glucose entry into cells, whereas PFK-1 activity more directly indicates whether carbon flux has entered the committed glycolytic stage.

(1) Increased PFK-1 activity

Increased PFK-1 activity usually indicates enhanced mid-pathway glycolytic flux. Fructose-6-phosphate, fructose-1,6-bisphosphate, lactate, ECAR, and ATP changes should be analyzed together to determine whether flux is transmitted downstream.

(2) Increased PFKFB3

Increased PFKFB3 often indicates that cells maintain high glycolytic flux by relieving ATP-mediated inhibition through fructose-2,6-bisphosphate. This marker has high interpretive value in hypoxia, inflammatory stimulation, and tumor proliferation models.

(3) Citrate accumulation accompanied by PFK-1 inhibition

Citrate accumulation can feedback-inhibit PFK-1, indicating changes in mitochondrial metabolism or lipid synthesis-related carbon flux. In this situation, glycolytic entry may still be active, but mid-pathway flux may be restricted.

4 Pyruvate Kinase Regulation: Terminal Energy Production and Metabolic Branching Control

4.1 Catalytic Reaction and Terminal Flux Function

Pyruvate kinase catalyzes the conversion of phosphoenolpyruvate into pyruvate while generating ATP. This step is the terminal irreversible reaction of glycolysis and determines whether upstream glycolytic intermediates are rapidly converted into pyruvate, thereby affecting lactate production, mitochondrial oxidation, and anabolic branches.

When PK activity is high, glycolytic carbon flux is more easily pushed toward pyruvate and lactate. When PK activity is reduced, upstream intermediates may accumulate and be redirected toward nucleotide synthesis, amino acid synthesis, or antioxidant metabolism-related branches. Therefore, PK is not simply a case of “the higher, the stronger the glycolysis”; its activity state directly affects the allocation of cellular carbon flux between energy production and biosynthesis.

4.2 Functional Differences Between PKM1 and PKM2

(1) PKM1

PKM1 usually has high and stable catalytic activity, promoting rapid conversion of phosphoenolpyruvate into pyruvate. It is more suitable for cellular states with stable energy demand and preference for efficient ATP generation.

(2) PKM2

PKM2 can switch between a high-activity tetrameric state and low-activity dimeric/monomeric states. High-activity PKM2 promotes terminal glycolytic reactions. Low-activity PKM2 allows upstream intermediates to accumulate and provides carbon sources for nucleotide, amino acid, and lipid synthesis. In tumor cells, PKM2 is often associated with proliferation, metabolic reprogramming, hypoxic responses, and signal transduction.

(3) PKL and PKR

PKL is mainly distributed in the liver and participates in hepatic glucose metabolism regulation. PKR is mainly found in red blood cells and is closely related to glycolytic energy supply in erythrocytes. Differences in PK isoenzymes among tissues affect the interpretation of experimental results.

4.3 Metabolic and Non-Metabolic Regulation of PKM2

PKM2 is regulated by fructose-1,6-bisphosphate, serine, tyrosine phosphorylation, oxidative modification, acetylation, and interacting proteins. Its conformation and oligomeric state determine catalytic activity and also influence the balance between energy generation and anabolic metabolism in tumor cells.

(1) Tetrameric PKM2

Tetrameric PKM2 has relatively high catalytic activity and can promote pyruvate and ATP generation. If the proportion of tetrameric PKM2 increases together with enhanced lactate production, this suggests that terminal glycolytic flux is being driven forward.

(2) Dimeric/monomeric PKM2

Low-activity PKM2 favors the accumulation of upstream glycolytic intermediates, allowing carbon flux to shift toward anabolic metabolism. In tumor cells, this state is often associated with proliferation, antioxidant adaptation, and metabolic plasticity.

(3) Nuclear localization of PKM2

PKM2 can participate in noncanonical transcriptional regulation and is related to signals such as HIF-1α and β-catenin. If increased nuclear localization of PKM2 is observed, it should not be interpreted only as glycolytic enzyme activity; proliferation, hypoxia, and transcriptional regulation markers should also be analyzed.

5 Functional Comparison of the Three Types of Rate-Limiting Enzymes

Table 1 Functional comparison of hexokinase, phosphofructokinase, and pyruvate kinase

5.1 Understanding the Three Types of Enzymes from Flux Direction

HK determines whether glucose can enter the cellular metabolic network, PFK-1 determines whether carbon flux enters the main glycolytic pathway, and PK determines whether terminal carbon flux is converted into pyruvate and outputs ATP. If glycolysis is viewed as a flux pipeline, HK controls the entry, PFK-1 controls the main valve, and PK controls the outlet and terminal branching. In experimental interpretation, any one rate-limiting enzyme should not be equated alone with the overall strength of glycolysis.

5.2 Understanding the Three Types of Enzymes from Metabolic Branching

(1) HK and glucose branching

The HK product glucose-6-phosphate is located at the intersection of multiple metabolic branches. Enhanced HK activity may support glycolysis, but it may also support the pentose phosphate pathway, glycogen synthesis, or the hexosamine pathway.

(2) PFK-1 and commitment to the main glycolytic pathway

PFK-1 is located at the committed step of the main glycolytic pathway, and enhanced PFK-1 activity more directly indicates that carbon flux enters downstream glycolysis. If PFK-1 is inhibited, increased glucose uptake may still result in upstream intermediate accumulation or diversion into branches.

(3) PK and anabolic balance

PK activity regulation determines whether the terminal glycolytic pathway rapidly outputs pyruvate. Low-activity PKM2 can support proliferating cells by retaining upstream intermediates for anabolic metabolism and redox balance.

6 Regulatory Significance in Diseases and Cellular States

6.1 Tumor Metabolic Reprogramming

Tumor cells often show enhanced glucose uptake, increased lactate production, and upregulated glycolytic enzyme expression. HK2, PFKFB3, and PKM2 are the most commonly studied nodes in tumor glycolytic reprogramming, but their functions are not equivalent.

(1) HK2 upregulation

HK2 upregulation enhances glucose trapping and may promote cell survival and anti-apoptotic capacity through mitochondrial localization.

(2) PFKFB3/PFK-1 enhancement

PFKFB3 enhancement can increase fructose-2,6-bisphosphate levels and drive PFK-1 flux, allowing tumor cells to maintain a high glycolytic state.

(3) PKM2 reprogramming

The low-activity state of PKM2 promotes accumulation of glycolytic intermediates, providing substrates for tumor cell proliferation and biosynthesis. PKM2 can also affect hypoxia and proliferation signals through non-metabolic functions.

6.2 Immune Cell Activation

T cells, macrophages, and dendritic cells undergo marked glycolytic enhancement during activation. HK2 upregulation helps rapidly increase glucose utilization, PFKFB3 and PFK-1 enhancement supports high-flux glycolysis, and PKM2 status affects inflammatory cytokine expression, effector function, and metabolic branching.

(1) Effector T cells

Effector T cells rely on rapid glycolysis to support proliferation and cytokine secretion. Enhanced HK and PFK flux is often consistent with activation status.

(2) Macrophage polarization

Pro-inflammatory macrophages often show enhanced glycolysis and increased lactate production, while PKM2 can participate in inflammation-related transcriptional regulation.

(3) Immunosuppressive microenvironment

High glycolysis in tumor cells can consume glucose and produce lactate, limiting the metabolic competitiveness of T cells and linking rate-limiting enzyme regulation with tumor immune status.

6.3 Hypoxia and Metabolic Stress

Hypoxia promotes the expression of glycolysis-related genes such as HK2, PFKFB3, and LDHA through HIF-1α, reducing cellular dependence on oxidative phosphorylation. In this state, HK and PFK nodes are often simultaneously enhanced, while PKM2 may support redistribution of carbon flux between energy generation and anabolic metabolism through changes in activity state.

7 Experimental Design and Result Evaluation

7.1 Combination of Detection Indicators

A single indicator is insufficient to accurately determine the regulatory status of glycolytic rate-limiting enzymes. Expression levels, enzyme activity, metabolites, flux, and functional endpoints should be integrated for comprehensive evaluation.

Table 2 Common detection indicators in glycolytic rate-limiting enzyme research

7.2 Common Experimental Misinterpretations

(1) Judging glycolysis only by lactate

Elevated lactate usually indicates enhanced glycolysis, but lactate levels are also affected by LDH activity, lactate transport, mitochondrial oxidation, and culture medium conditions. When interpreting rate-limiting enzyme regulation, glucose consumption, ECAR, enzyme activity, and metabolic intermediates should be detected simultaneously.

(2) Focusing only on enzyme expression

The expression levels of HK, PFK, and PK do not fully represent enzyme activity. PFK-1 is strongly affected by allosteric regulation, and PKM2 is markedly influenced by conformation and post-translational modifications. Therefore, activity assays and metabolite changes should also be included.

(3) Ignoring isoenzyme differences

Different isoenzymes have different tissue distributions, kinetic characteristics, and regulatory modes. The functional differences between HK2 and HK1, as well as between PKM2 and PKM1, are particularly important in tumor and immunometabolism research.

(4) Ignoring metabolic branching

Increased HK may enhance the pentose phosphate pathway, and low-activity PKM2 may promote anabolic branching. Regulation of glycolytic rate-limiting enzymes should not be interpreted only by “how much lactate is produced”; cell proliferation, antioxidant status, and biosynthetic demand should also be considered.

8 Related Reagent and Material Selection

Table 3 Products related to glycolytic rate-limiting enzyme proteins, activity detection, and expression detection

Table 4 Products related to glycolytic flux, terminal products, and branch metabolism evaluation

Table 5 Products related to glycolytic rate-limiting enzyme validation, tumor metabolism, and hypoxic response

9 Frequently Asked Questions

9.1 Why is PFK-1 usually considered the most central rate-limiting enzyme in glycolysis?

PFK-1 is located at the committed step of the main glycolytic pathway and directly determines whether fructose-6-phosphate enters downstream glycolytic reactions. HK controls glucose entry into the metabolic network, but its product can enter multiple branches. PK controls terminal output, but cannot independently determine mid-pathway flux. Therefore, PFK-1 more appropriately represents commitment of the main glycolytic flux.

9.2 Does increased HK2 necessarily indicate enhanced glycolysis?

Not necessarily. Increased HK2 indicates enhanced glucose trapping and phosphorylation capacity, but glucose-6-phosphate may enter glycolysis, the pentose phosphate pathway, glycogen synthesis, or the hexosamine pathway. Lactate, ECAR, metabolic intermediates, and flux assays are needed for judgment.

9.3 Why is PKM2 widely studied in tumor metabolism?

PKM2 can function as a terminal glycolytic enzyme regulating pyruvate formation and can also affect anabolic branching through different conformational states. Low-activity PKM2 favors the accumulation of upstream intermediates, providing a metabolic basis for tumor cell proliferation and antioxidant adaptation.

9.4 Can elevated lactate directly indicate that all three rate-limiting enzymes are activated?

No. Increased lactate may result from enhanced glucose uptake, increased PFK flux, enhanced PK terminal output, or increased LDH activity, and may also be affected by lactate transport. Interpreting rate-limiting enzyme regulation requires integrating enzyme activity, protein expression, metabolic intermediates, and functional experiments.

9.5 Which indicators should be prioritized when studying glycolytic rate-limiting enzymes?

Basic studies can prioritize HK2, PFKFB3/PFK-1, PKM2, glucose consumption, lactate production, and ATP levels. To determine flux direction, ECAR/OCR, pyruvate, NADPH, isotope tracing, and key intermediate detection should be further included.

Hexokinase, phosphofructokinase, and pyruvate kinase respectively control glycolytic entry, mid-pathway commitment, and terminal output. Together, they determine the allocation of glucose-derived carbon flux among energy production, lactate generation, and anabolic metabolism. Only by integrating isoenzyme expression, enzyme activity changes, metabolite levels, and flux results can the regulatory roles of glycolytic rate-limiting enzymes in tumor metabolism, immune cell activation, and hypoxic adaptation be accurately interpreted.

For more related articles, please see below:

[1] Techniques for Assessing Cellular Energy Metabolism: Core Mechanisms of Glycolysis and the TCA Cycle, with Practical Assay-Kit Workflows

[2] Molecular Characteristics and Technological Applications of Hexokinase